New York City, NY -- (SBWIRE) -- 12/12/2013 -- StockMarketIntel.com issues a special report on the following stocks: DARA Biosciences Inc (NASDAQ:DARA), North American Palladium Ltd (USA) (NYSEMKT:PAL), Bio Matrix Scientific Group Inc (OTCMKTS:BMSN), Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV)
DARA Biosciences Inc (NASDAQ:DARA) gained 3.53%, trading on 3.00 million shares, to end the trade at $0.502. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.45 and was moved to the maximum level of $1.20. The stock changed hands in a range of $0.49 to $0.54, bringing its market capitalization to about $15.55 million. DARA BioSciences, Inc., a development stage biopharmaceutical company, engages in the development and commercialization of oncology treatment and supportive care pharmaceutical products in the United Sates. It offers Soltamox for the chronic treatment of breast cancer or for cancer prevention in certain susceptible breast cancer subgroups.
For How Long DARA Gloss will Attract Investors? Find out via this report
North American Palladium Ltd (USA) (NYSEMKT:PAL) declined -3.85%, to complete the trading session at $0.452, with a total volume of 2.87 million shares. The stock, on average, trades on a volume of 2.28 million shares. In the past 52 weeks, the share price has not declined below $0.37 and above $1.98. It floated in a range of $0.44 to $0.49 during the last trading session, with a beta value of 2.31. Its market capitalization now moved to about $88.95 million. North American Palladium Ltd. produces precious metals in Canada. It explores for palladium, platinum, nickel, gold, copper, and other metals. The company primarily holds interest in the Lac des Iles property that covers approximately 8,649 hectares of mineral claims and leases located northwest of the city of Thunder Bay, Ontario.
Will PAL Bounce Back After yesterday’s Sharp Sell off? Find Out Here
Bio Matrix Scientific Group Inc (OTCMKTS:BMSN) recorded a gain of 18.75% and was in a range of $0.0015-$0.0027 before closing at $0.0019. The share price hit its 52-week low of $0.0002 and $0.0165 was the best price. The stock completed the day with a total volume of 228.16 million shares, versus an average volume of 25.46 million shares. Bio-Matrix Scientific Group, Inc., a development stage company, intends to engage primarily in the development of regenerative medical applications. It develops HemaXellerate, a cellular drug to heal damaged bone marrow; and HemaXellerate I, which is a patient-specific composition of cells that have been demonstrated to repair damaged bone marrow and stimulate production of blood cells based on previous animal studies.
Will BMSN Continue To Move Higher? Find Out Here
Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) added 0.11% yesterday, bringing its market capitalization around $140.30 million. The total number of shares that changed hands during the session was 691,165 shares, as compared to average trading volume of 345,514 shares. The share price, after opening at $1.76, made a high of $2.17 and hovered above $1.76 to end the day at $1.78. Invivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions. It intends to develop and commercialize biocompatible polymer scaffolding devices to treat acute spinal cord injuries; biocompatible hydrogel for use as dural sealants, dural replacements, and nerve conduits, as well as for local controlled release of methylprednisolone to treat spinal cord injuries and peripheral nerve injuries; and biocompatible polymer scaffolding devices seeded with autologous human neural stem cells to treat acute and chronic spinal cord injuries.
Why Should Investors Buy NVIV After The Recent Gain? Just Go Here and Find Out
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)